ATE194921T1 - Verfahren zur inaktivierung von viren - Google Patents

Verfahren zur inaktivierung von viren

Info

Publication number
ATE194921T1
ATE194921T1 AT93907173T AT93907173T ATE194921T1 AT E194921 T1 ATE194921 T1 AT E194921T1 AT 93907173 T AT93907173 T AT 93907173T AT 93907173 T AT93907173 T AT 93907173T AT E194921 T1 ATE194921 T1 AT E194921T1
Authority
AT
Austria
Prior art keywords
inactivation
viruses
supercritical
directed
methods
Prior art date
Application number
AT93907173T
Other languages
English (en)
Inventor
Trevor P Castor
Arthur D Lander
Original Assignee
Bioeng Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioeng Inc filed Critical Bioeng Inc
Application granted granted Critical
Publication of ATE194921T1 publication Critical patent/ATE194921T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93907173T 1992-03-02 1993-03-02 Verfahren zur inaktivierung von viren ATE194921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84451392A 1992-03-02 1992-03-02
PCT/US1993/001916 WO1993017724A1 (en) 1992-03-02 1993-03-02 Viral inactivation method

Publications (1)

Publication Number Publication Date
ATE194921T1 true ATE194921T1 (de) 2000-08-15

Family

ID=25292924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93907173T ATE194921T1 (de) 1992-03-02 1993-03-02 Verfahren zur inaktivierung von viren

Country Status (6)

Country Link
US (2) US5877005A (de)
EP (1) EP0629135B1 (de)
JP (1) JP4260877B2 (de)
AT (1) ATE194921T1 (de)
DE (1) DE69329108T2 (de)
WO (1) WO1993017724A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4260877B2 (ja) * 1992-03-02 2009-04-30 バイオエング・インコーポレーテッド ウイルスの不活性化方法
FR2699408B1 (fr) * 1992-12-21 1995-03-24 Bioland Procédé de traitement de tissus osseux et biomatériaux implantables correspondants.
US5723012A (en) * 1993-12-09 1998-03-03 Bioland Uses for a current of supercritical carbon dioxide as an antiviral agent
FR2735372B1 (fr) * 1995-06-13 1997-09-05 Bioland Nouvelles utilisations d'un courant de dioxyde de carbone supercritique a titre d'agent antiviral
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US6149864A (en) * 1998-06-25 2000-11-21 Massachusetts Institute Of Technology Supercritical fluid sterilization method
EP1170022A4 (de) * 1999-12-27 2003-02-05 Sr Kaihatsu Kk Verfahren und vorrichtung zur desinfektion/sterilisation von medizinischen instrumenten
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
EP1409108A4 (de) * 2001-06-25 2007-11-14 Lipid Sciences Inc Hohlfaserberührungssysteme zur entfernung von lipiden aus fluiden
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US7033500B2 (en) * 2001-06-25 2006-04-25 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
EP1412045A4 (de) * 2001-06-25 2007-05-02 Lipid Sciences Inc Ein lösungsmittel zur entfernung von lipiden aus fluiden verwendende systeme und verfahren
US7033813B2 (en) * 2001-09-05 2006-04-25 Trevor P Castor Inactivated vaccines for aids and other infectious diseases
US7029707B2 (en) * 2001-10-03 2006-04-18 Herbalscience, Llc Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
US7291352B2 (en) 2001-10-03 2007-11-06 Herbalscience Llc Methods and compositions for oral delivery of Areca and mate' or theobromine
US20050069596A1 (en) * 2001-10-03 2005-03-31 Gow Robert T. Compositions and methods comprising kava and anti-anxiety compounds
US7001620B2 (en) 2001-10-03 2006-02-21 Herbal Science, Llc Kavalactone product
US7105185B2 (en) 2001-10-03 2006-09-12 Herbalscience, Llc Kavalactone profile
US20050053678A1 (en) * 2001-10-03 2005-03-10 Gow Robert T. Methods and compositions for betel nut chewing gum
US7037524B2 (en) * 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
US7008591B2 (en) * 2001-10-17 2006-03-07 Edwards Lifesciences Corporation Supercritical fluid extraction process for tissue preparation
US20040106556A1 (en) * 2002-08-26 2004-06-03 Yanhong Zhu Method of treating and preventing alzheimer disease through administration of delipidated protein and lipoprotein particles
US20050037025A1 (en) * 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
CA2531227A1 (en) 2003-07-03 2005-02-10 Lipid Sciences Inc. Methods and apparatus for creating particle derivatives of hdl with reduced lipid content
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
US7294353B2 (en) * 2003-10-24 2007-11-13 Herbalscience, Llc Methods and compositions comprising ilex
CN1917892A (zh) * 2003-10-24 2007-02-21 草本制药科学有限责任公司 包含冬青的方法和组合物
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
WO2005065396A2 (en) 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US7387749B2 (en) * 2004-02-20 2008-06-17 Wayne State University Method of delaminating aggregated particles with a coating agent in a substantially supercritical fluid
TWI302944B (en) * 2004-07-12 2008-11-11 Method for removing virus activity from biological materials
CN1318581C (zh) * 2004-07-13 2007-05-30 南玮实业股份有限公司 利用超临界流体去除冠状病毒活性的方法
US20060269928A1 (en) * 2005-05-27 2006-11-30 Aphios Corporation Compositions, methods and apparatus for supercritical fluid virus inactivation
CN101365499A (zh) * 2005-11-01 2009-02-11 骨骼技术股份有限公司 骨基质组合物和方法
KR20080005678A (ko) * 2006-07-10 2008-01-15 삼성전자주식회사 인쇄회로기판 및 이를 갖는 전자장치
WO2008157492A2 (en) * 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
CA2690457C (en) 2007-06-15 2018-02-20 Osteotech, Inc. Bone matrix compositions and methods
CA3062443C (en) * 2007-06-15 2022-03-15 Warsaw Orthopedic, Inc. Method of treating tissue
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
WO2009009684A1 (en) * 2007-07-10 2009-01-15 Osteotech, Inc. Delivery system
CA2694854C (en) 2007-08-17 2016-09-27 Csl Behring Gmbh Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
US8202539B2 (en) * 2007-10-19 2012-06-19 Warsaw Orthopedic, Inc. Demineralized bone matrix compositions and methods
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
WO2010093959A2 (en) 2009-02-12 2010-08-19 Osteotech, Inc. Delivery systems, tools, and methods of use
US20100322943A1 (en) 2009-06-17 2010-12-23 Thomas Cantor Therapeutic and diagnostic affinity purified specific polyclonal antibodies
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
US20120302499A1 (en) 2011-05-27 2012-11-29 Matheny Robert G Sterilized, acellular extracellular matrix compositions and methods of making thereof
US8956566B2 (en) 2012-03-12 2015-02-17 Pure Biosolutions, Llc System and method for virus inactivation
WO2014004103A1 (en) 2012-06-29 2014-01-03 Emd Millipore Corporation Methods for inactivating viruses during a protein purification process
US8791054B2 (en) * 2012-09-27 2014-07-29 Halliburton Energy Services, Inc. Methods of converting an inactive biocide into an active biocide using a chemical reaction
KR102465762B1 (ko) * 2014-10-24 2022-11-09 젠자임 코포레이션 멸균 공정 용기로부터의 유체 스트림에 대한 통합형 연속식 단리
EP3088006A1 (de) * 2015-04-28 2016-11-02 Bayer Technology Services GmbH Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor
JP2018082987A (ja) * 2016-11-25 2018-05-31 株式会社日立製作所 ウイルス不活化方法及びウイルス不活化装置
CA3083194A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
AU2018396009A1 (en) 2017-12-28 2020-07-16 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
RU2691983C1 (ru) * 2018-02-27 2019-06-19 Общество с ограниченной ответственностью "Матрифлекс" Способ очистки, модификации и стерилизации производных костной ткани и кожного матрикса с использованием сверхкритического флюида
TWI724396B (zh) * 2018-03-30 2021-04-11 日商旭化成醫療股份有限公司 血液淨化器及其製法
EP4028511A1 (de) * 2019-09-09 2022-07-20 Valneva Austria GmbH Inaktivierungsverfahren für viren
WO2023063933A1 (en) * 2020-10-12 2023-04-20 Castor Trevor P Apparatus and method for inactivating viruses and pathogens in human plasma units
US20220111082A1 (en) * 2020-10-12 2022-04-14 Trevor P. Castor Terminal sterilization of biologics
WO2022109430A1 (en) * 2020-11-22 2022-05-27 Castor Trevor P Sustained release inactivated vaccines
US20240350691A1 (en) * 2021-10-12 2024-10-24 Aphios Corporation Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32695E (en) * 1979-04-12 1988-06-14 Dasi Industries, Inc. Method and apparatus for treating fluent materials
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
WO1991001367A1 (en) * 1989-07-20 1991-02-07 Bioeng, Inc. Supercritical fluid disruption of and extraction from microbial cells
JP4260877B2 (ja) * 1992-03-02 2009-04-30 バイオエング・インコーポレーテッド ウイルスの不活性化方法
US5520943A (en) * 1993-10-27 1996-05-28 Nippon Tansan Co., Ltd. Method for modifying the quality of liquid foodstuff
US5667835A (en) * 1993-10-27 1997-09-16 Nippan Tansan Co., Ltd. Method for inactivating enzymes, microorganisms and spores in a liquid foodstuff

Also Published As

Publication number Publication date
JPH07505071A (ja) 1995-06-08
DE69329108T2 (de) 2001-03-22
EP0629135A1 (de) 1994-12-21
US6465168B1 (en) 2002-10-15
DE69329108D1 (de) 2000-08-31
WO1993017724A1 (en) 1993-09-16
EP0629135B1 (de) 2000-07-26
JP4260877B2 (ja) 2009-04-30
US5877005A (en) 1999-03-02

Similar Documents

Publication Publication Date Title
ATE194921T1 (de) Verfahren zur inaktivierung von viren
ATE80803T1 (de) Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
DE68921948D1 (de) System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien.
DE69635871D1 (de) Verfahren und Zusammensetzungen zur selektiven Modikation von Nukleinsäuren
DE69030596D1 (de) Verfahren und Vorrichtung zur Behandlung von Proben
ATE73351T1 (de) Verfahren zur sterilisation von plasma oder plasmafraktionen.
ATE191513T1 (de) Verfahren zur amplifikation von nukleinsäuren
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE3789158D1 (de) Verfahren zur Sterilisation und Vorrichtung dafür.
ATE138575T1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
DE69829625D1 (de) Verfahren und Vorrichtung zur Behandlung von Perfluorokohlenstoff
DE69525473D1 (de) Vorrichtung zur behandlung von blutgefässen
DE69839093D1 (de) System zur behandlung von blut und verfahren zur optischen bestimmung des volumens der im plasma enthaltenen blutplättchen
DE69435010D1 (de) Verfahren und stoffe für die behandlung von individuen, die infiziert sind mit intrazellulär infektiösen agentien
DE3885358D1 (de) Vorrichtung und verfahren zur behandlung des randes eines brillenglases.
DE3781535D1 (de) Verfahren und vorrichtung zur aseptischen behandlung von lebensmitteln.
DE69023859D1 (de) Verfahren und Vorrichtung zur quantitativen Bestimmung von Chemikalien zur Behandlung von Halbleitern.
BR9204699A (pt) Compostos contendo grupamento imidazolinona ou imidazolintiona,processos de preparacoes desses compostos,composicoes fungicidas e processo de tratamento de culturas
DE69941157D1 (de) Verfahren und vorrichtung zur behandlung von blutplasma oder blutplasmakonzentrat
DE3486317D1 (de) Vorrichtung und Verfahren zur Plasmabehandlung von Kunstharz.
PT79117A (de) Verfahren zur pasteurisierung von humanplasma
DE68910928D1 (de) Verfahren und Vorrichtung zur zentrifugalen Behandlung von Flüssigkeiten.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
ATA71392A (de) Verfahren zur aktivierung von blutgerinnungsfaktoren
DE3775426D1 (de) Verfahren zur behandlung von gasoelen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee